Yuan Sheng

1.5k citations
38 papers · 775 indexed · h-index 13
Topics
Breast Cancer Treatment Studies (7 papers)Cancer Treatment and Pharmacology (4 papers)HER2/EGFR in Cancer Research (3 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaOncogene
Partner nations
ChinaUnited StatesFrance

In The Last Decade

Yuan Sheng

36 papers receiving 770 citations

Peers

Yuan Sheng
Comparison fields: 5 of 96
  • Molecular Biology 378
  • Cancer Research 214
  • Oncology 161
  • Surgery 145
  • Physiology 145
Replace Rosa Divella with:
Rosa Divella Italy
Jia Fei China
Sarra Setrerrahmane China
Shouli Wang China
Francesco Mariani Italy
Xuan Zhao China
Liqiang Song China
Susan Heavey United Kingdom
Nicole M. Fletcher United States
Chenglong Li China
Yuan Sheng relative to Rosa Divella Italy Rosa Divella's profile →
Citations per field
00.5×
Rosa Divella · 1×
Citations per year

Countries citing papers authored by Yuan Sheng

Since Specialization
Citations

This map shows the geographic impact of Yuan Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Sheng more than expected).

Fields of papers citing papers by Yuan Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Sheng. The network helps show where Yuan Sheng may publish in the future.

Co-authorship network of co-authors of Yuan Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Sheng. A scholar is included among the top collaborators of Yuan Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Sheng. Yuan Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 0
3 4
4 3
5 1
6 0
7 1
8 1
9 4
10 5
11 13
12 136
13 44
14 38
15 34
16 10
17 74
18 3
19 4
20
[Application of central lymph node dissection to surgical operation for clinical stage n0 papillary thyroid carcinoma].
2

About Yuan Sheng

Yuan Sheng is a scholar working on Cancer Research, Oncology and Genetics, having authored 38 papers that have together received 775 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cancer Research (214 citations), Oncology (161 citations) and Physiology (145 citations). Yuan Sheng has collaborated with scholars based in China, United States and France. Frequent co-authors include Zhiping Huang, Yan Guo, Chaoqian Liu, Lin Qi, Dajin Zou, Feifei Xu, Yanmei Wu, Xia Li, Yun Chen and Yalei Jin. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026